ABSTRACT
@#The immunodeficiency is too common in whole the world including this country. The myocardial Infarct, stroke, atherosclerosis and many other disorders develops in fact secondary immune deficit of human being. </br> We aimed to study the immune stimulating capacity of transfer factor advanced which used more than 50 countries in the world as a strong immune modulator, comparatively with other commonly used convalescents in our traditional medicine like bargashun and altan gagnuur and their membrane pereoxidase potential as well. </br> For this study were used white mouse’s with 20-25g of weights. All mouse’s were taken orally 0.05g of transfer factor advanced during 3 days 2 times per day and at the end were injected with 0.2 ml - 10% fresh red cell of sheep once which chosen as T-cell dependent stimulator test antigen. 5 days later were examined spleen index and counted newly generated antibody titer against sheep red cell. </br> The study result show that under the influence of transfer factor advanced after immunization (by 100 mg/mouse sheep red cell), the amount of cytotoxic T lymphocyte (T killer) cells among whole T lymphocyte population in the spleen and nearby lymph nodes of white mouse’s were perceptibly increased (1.43-2.33 P<0.001). It gives to conclude transfer factor advanced should have high treatment effects for several cancers, chronic liver disorders with B and C viruses hepatitis, cirrhoses etc., which develops due to deficit of T killer cell.